Cellular Senescence and Chromatin Organisation

Overview

Journal Br J Cancer

Specialty Oncology

Date 2007 Feb 22

PMID 17311013

Citations 33

Authors

M Narita

Affiliations

Soon will be listed here.

Abstract

Despite the potential importance of senescence in tumour suppression, its effector mechanism is poorly understood. Recent studies suggest that alterations in the chromatin environment might add an additional layer of stability to the phenotype. In this review, recent discoveries on the interplay between senescence and chromatin biology are overviewed.

Citing Articles

H2AJ Is a Direct Androgen Receptor Target Gene That Regulates Androgen-Induced Cellular Senescence and Inhibits Mesenchymal Markers in Prostate Cancer Cells.

Heidari Horestani M, Atri Roozbahani G, Baniahmad A Cancers (Basel). 2025; 17(5).

PMID: 40075640 PMC: 11898987. DOI: 10.3390/cancers17050791.

PQBP3 prevents senescence by suppressing PSME3-mediated proteasomal Lamin B1 degradation.

Yoshioka Y, Huang Y, Jin X, Ngo K, Kumaki T, Jin M EMBO J. 2024; 43(18):3968-3999.

PMID: 39103492 PMC: 11405525. DOI: 10.1038/s44318-024-00192-4.

Towards Healthy Longevity: Comprehensive Insights from Molecular Targets and Biomarkers to Biological Clocks.

Yusri K, Kumar S, Fong S, Gruber J, Sorrentino V Int J Mol Sci. 2024; 25(12).

PMID: 38928497 PMC: 11203944. DOI: 10.3390/ijms25126793.

Writers and readers of H3K9me2 form distinct protein networks during the cell cycle that include candidates for H3K9 mimicry.

Pollin G, de Assuncao T, Jorge S, Chi Y, Charlesworth M, Madden B Biosci Rep. 2023; 43(10).

PMID: 37782747 PMC: 10611923. DOI: 10.1042/BSR20231093.

A pro-oxidant combination of resveratrol and copper down-regulates multiple biological hallmarks of ageing and neurodegeneration in mice.

Pal K, Raghuram G, DSouza J, Shinde S, Jadhav V, Shaikh A Sci Rep. 2022; 12(1):17209.

PMID: 36241685 PMC: 9568542. DOI: 10.1038/s41598-022-21388-w.

References

Francastel C, Schubeler D, Martin D, Groudine M . Nuclear compartmentalization and gene activity. Nat Rev Mol Cell Biol. 2001; 1(2):137-43. DOI: 10.1038/35040083. View

Reeves R . Molecular biology of HMGA proteins: hubs of nuclear function. Gene. 2001; 277(1-2):63-81. DOI: 10.1016/s0378-1119(01)00689-8. View

Te Poele R, Okorokov A, Jardine L, Cummings J, Joel S . DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 2002; 62(6):1876-83. View

Schmitt C, Fridman J, Yang M, Lee S, Baranov E, Hoffman R . A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell. 2002; 109(3):335-46. DOI: 10.1016/s0092-8674(02)00734-1. View

Plath K, Fang J, Mlynarczyk-Evans S, Cao R, Worringer K, Wang H . Role of histone H3 lysine 27 methylation in X inactivation. Science. 2003; 300(5616):131-5. DOI: 10.1126/science.1084274. View

Narita M, Nunez S, Heard E, Narita M, Lin A, Hearn S . Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell. 2003; 113(6):703-16. DOI: 10.1016/s0092-8674(03)00401-x. View

Beausejour C, Krtolica A, Galimi F, Narita M, Lowe S, Yaswen P . Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J. 2003; 22(16):4212-22. PMC: 175806. DOI: 10.1093/emboj/cdg417. View

dAdda di Fagagna F, Reaper P, Clay-Farrace L, Fiegler H, Carr P, von Zglinicki T . A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003; 426(6963):194-8. DOI: 10.1038/nature02118. View

Ait-Si-Ali S, Guasconi V, Fritsch L, Yahi H, Sekhri R, Naguibneva I . A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. EMBO J. 2004; 23(3):605-15. PMC: 1271807. DOI: 10.1038/sj.emboj.7600074. View

10.

Herbig U, Jobling W, Chen B, Chen D, Sedivy J . Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell. 2004; 14(4):501-13. DOI: 10.1016/s1097-2765(04)00256-4. View

11.

Takaha N, Resar L, Vindivich D, Coffey D . High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase-2 expression in prostate cancer cells. Prostate. 2004; 60(2):160-7. DOI: 10.1002/pros.20049. View

12.

Hirakawa T, Ruley H . Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene. Proc Natl Acad Sci U S A. 1988; 85(5):1519-23. PMC: 279804. DOI: 10.1073/pnas.85.5.1519. View

13.

Lanahan A, Williams J, Sanders L, Nathans D . Growth factor-induced delayed early response genes. Mol Cell Biol. 1992; 12(9):3919-29. PMC: 360271. DOI: 10.1128/mcb.12.9.3919-3929.1992. View

14.

Zhou X, Benson K, Ashar H, Chada K . Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature. 1995; 376(6543):771-4. DOI: 10.1038/376771a0. View

15.

Dimri G, Lee X, Basile G, Acosta M, Scott G, Roskelley C . A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995; 92(20):9363-7. PMC: 40985. DOI: 10.1073/pnas.92.20.9363. View

16.

Serrano M, Lin A, McCurrach M, Beach D, Lowe S . Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997; 88(5):593-602. DOI: 10.1016/s0092-8674(00)81902-9. View

17.

Berner J, Meza-Zepeda L, Kools P, Forus A, Schoenmakers E, Van de Ven W . HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas. Oncogene. 1997; 14(24):2935-41. DOI: 10.1038/sj.onc.1201135. View

18.

Mantovani F, Covaceuszach S, Rustighi A, Sgarra R, Heath C, Goodwin G . NF-kappaB mediated transcriptional activation is enhanced by the architectural factor HMGI-C. Nucleic Acids Res. 1998; 26(6):1433-9. PMC: 147413. DOI: 10.1093/nar/26.6.1433. View

19.

Costanzi C, Pehrson J . Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature. 1998; 393(6685):599-601. DOI: 10.1038/31275. View

20.

Hayflick L . THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res. 1965; 37:614-36. DOI: 10.1016/0014-4827(65)90211-9. View